Zydus Therapeutics announces positive topline results from EPICS-III Phase 2b/3 trial of Saroglitazar in Primary Biliary Cholangitis Read more
FDA approves Pfizer-BioNTech LP.8.1-adapted monovalent COVID-19 vaccine for high-risk groups Read more
Eli Lilly announces Phase 3 ATTAIN-2 trial results for oral GLP-1 agonist orforglipron in obesity and type 2 diabetes Read more
Novartis and BioArctic sign collaboration agreement on BrainTransporter technology for neurological drug development Read more
FOPE & PharmaState Academy advance MSME excellence with PULSE session 24 on contract management Read more